Publications by authors named "Rosa A Seminario-Amez"
Asprosin levels in patients with type 2 diabetes mellitus, metabolic syndrome and obesity: A systematic review and meta-analysis.
Juan R Ulloque-Badaracco Ali Al-Kassab-Córdova Enrique A Hernandez-Bustamante Esteban A Alarcon-Braga Pamela Robles-Valcarcel Rosa A Seminario-Amez
Diabetes Metab Syndr
July 2024
Article Synopsis
- This study reviews existing research on asprosin levels in patients with type 2 diabetes (T2D), metabolic syndrome (MetS), and obesity to explore its potential as a treatment for metabolic-endocrine disorders.
- A systematic analysis of 26 studies found that individuals with T2D, MetS, and obesity had significantly higher asprosin levels compared to those without these conditions.
- The results suggest that asprosin could serve as a biomarker for metabolic disorders, as its levels are notably elevated in T2D, MetS, and obesity patients.
Background And Aims: The presence of fungal infections has been described in patients after recovering from COVID-19. This study aims to conduct a systematic review of studies that reported fungal infections ( spp., , or spp.
View Article and Find Full Text PDFArticle Synopsis
- - The study aimed to analyze and summarize data about the prevalence of human toxocariasis in Latin America and the Caribbean by examining 101 articles that included over 31,000 participants.
- - The overall seroprevalence of toxocariasis was found to be 31.0%, with notable findings indicating higher rates among pet owners and lower rates in adult-only populations.
- - The research highlights the need for improved epidemiological surveillance strategies to prevent and identify toxocariasis, as the disease is significant in areas with high prevalence.
Background & Aims: Apolipoproteins and lipoprotein(a) are associated with various cardiometabolic diseases, including insulin resistance, diabetes mellitus, hypertension, dyslipidemia, among others. This systematic review and meta-analysis was conducted to evaluate the association of these markers with metabolic syndrome (MetS).
Methods: We ran a systematic search through PubMed, Scopus, Embase, Ovid/Medline, and Web of Science on March 15, 2023.